Analysts Set Elevance Health, Inc. (NYSE:ELV) Price Target at $519.81
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seventeen analysts that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy […]
Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seventeen analysts that are presently covering the company, MarketBeat reports. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy […]